Eisenmenger Syndrome Treatment Market, Global Outlook and Forecast 2022-2028

January 2022 | 62 pages | ID: EE8BD8653048EN
Market Monitor Global

Abstracts

The triad of congenital systemic-to-pulmonary communication, cyanosis, and pulmonary arterial disease is called Eisenmenger syndrome. Eisenmenger syndrome is caused due to a birth defect. The disease is characterized by high blood pressure and abnormal blood flow through the heart. The specific symptoms of Eisenmenger syndrome vary greatly from person to person. The most notable symptom is called cyanosis, which is the bluish discoloration of the skin and mucous membranes. Eisenmenger syndrome is caused by a defect in the structure of the heart, more specifically a ventricular septal defect (VSD) or other shunt. Eisenmenger syndrome belongs to a group of conditions called pulmonary arterial hypertension-PAH.

This report contains market size and forecasts of Eisenmenger Syndrome Treatment in Global, including the following market information:

Global Eisenmenger Syndrome Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Eisenmenger Syndrome Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antiarrhythmic Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Eisenmenger Syndrome Treatment include Actelion Pharmaceuticals Ltd., Gilead Sciences, Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca plc., Novartis AG, Merck & Co., Inc., GlaxoSmithKline plc. and Mylan N.V. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Eisenmenger Syndrome Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Eisenmenger Syndrome Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Eisenmenger Syndrome Treatment Market Segment Percentages, by Type, 2021 (%)

• Antiarrhythmic Agents
• Blood Thinning Agents
• Endothelin Receptor Antagonist
• Others

Global Eisenmenger Syndrome Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Eisenmenger Syndrome Treatment Market Segment Percentages, by Application, 2021 (%)

• Blood tests
• Electrocardiogram (ECG)
• Chest X-ray
• Echocardiogram
• Computerized tomography (CT) scan
• Magnetic resonance imaging (MRI)
• Cardiac catheterization
• Walking test

Global Eisenmenger Syndrome Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Eisenmenger Syndrome Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Eisenmenger Syndrome Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Eisenmenger Syndrome Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Actelion Pharmaceuticals Ltd.
• Gilead Sciences, Inc.
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• AstraZeneca plc.
• Novartis AG
• Merck & Co., Inc.
• GlaxoSmithKline plc.
• Mylan N.V.
• Bayer AG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Eisenmenger Syndrome Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Eisenmenger Syndrome Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EISENMENGER SYNDROME TREATMENT OVERALL MARKET SIZE

2.1 Global Eisenmenger Syndrome Treatment Market Size: 2021 VS 2028
2.2 Global Eisenmenger Syndrome Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Eisenmenger Syndrome Treatment Players in Global Market
3.2 Top Global Eisenmenger Syndrome Treatment Companies Ranked by Revenue
3.3 Global Eisenmenger Syndrome Treatment Revenue by Companies
3.4 Top 3 and Top 5 Eisenmenger Syndrome Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Eisenmenger Syndrome Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Eisenmenger Syndrome Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Eisenmenger Syndrome Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Eisenmenger Syndrome Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Eisenmenger Syndrome Treatment Market Size Markets, 2021 & 2028
  4.1.2 Antiarrhythmic Agents
  4.1.3 Blood Thinning Agents
  4.1.4 Endothelin Receptor Antagonist
  4.1.5 Others
4.2 By Type - Global Eisenmenger Syndrome Treatment Revenue & Forecasts
  4.2.1 By Type - Global Eisenmenger Syndrome Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Eisenmenger Syndrome Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Eisenmenger Syndrome Treatment Market Size, 2021 & 2028
  5.1.2 Blood tests
  5.1.3 Electrocardiogram (ECG)
  5.1.4 Chest X-ray
  5.1.5 Echocardiogram
  5.1.6 Computerized tomography (CT) scan
  5.1.7 Magnetic resonance imaging (MRI)
  5.1.8 Cardiac catheterization
  5.1.9 Walking test
5.2 By Application - Global Eisenmenger Syndrome Treatment Revenue & Forecasts
  5.2.1 By Application - Global Eisenmenger Syndrome Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Eisenmenger Syndrome Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Eisenmenger Syndrome Treatment Market Size, 2021 & 2028
6.2 By Region - Global Eisenmenger Syndrome Treatment Revenue & Forecasts
  6.2.1 By Region - Global Eisenmenger Syndrome Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Eisenmenger Syndrome Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Eisenmenger Syndrome Treatment Revenue, 2017-2028
  6.3.2 US Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.3.3 Canada Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.3.4 Mexico Eisenmenger Syndrome Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Eisenmenger Syndrome Treatment Revenue, 2017-2028
  6.4.2 Germany Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.4.3 France Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.4.4 U.K. Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.4.5 Italy Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.4.6 Russia Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.4.8 Benelux Eisenmenger Syndrome Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Eisenmenger Syndrome Treatment Revenue, 2017-2028
  6.5.2 China Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.5.3 Japan Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.5.4 South Korea Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.5.6 India Eisenmenger Syndrome Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Eisenmenger Syndrome Treatment Revenue, 2017-2028
  6.6.2 Brazil Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.6.3 Argentina Eisenmenger Syndrome Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Eisenmenger Syndrome Treatment Revenue, 2017-2028
  6.7.2 Turkey Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.7.3 Israel Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Eisenmenger Syndrome Treatment Market Size, 2017-2028
  6.7.5 UAE Eisenmenger Syndrome Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Actelion Pharmaceuticals Ltd.
  7.1.1 Actelion Pharmaceuticals Ltd. Corporate Summary
  7.1.2 Actelion Pharmaceuticals Ltd. Business Overview
  7.1.3 Actelion Pharmaceuticals Ltd. Eisenmenger Syndrome Treatment Major Product Offerings
  7.1.4 Actelion Pharmaceuticals Ltd. Eisenmenger Syndrome Treatment Revenue in Global Market (2017-2022)
  7.1.5 Actelion Pharmaceuticals Ltd. Key News
7.2 Gilead Sciences, Inc.
  7.2.1 Gilead Sciences, Inc. Corporate Summary
  7.2.2 Gilead Sciences, Inc. Business Overview
  7.2.3 Gilead Sciences, Inc. Eisenmenger Syndrome Treatment Major Product Offerings
  7.2.4 Gilead Sciences, Inc. Eisenmenger Syndrome Treatment Revenue in Global Market (2017-2022)
  7.2.5 Gilead Sciences, Inc. Key News
7.3 Pfizer, Inc.
  7.3.1 Pfizer, Inc. Corporate Summary
  7.3.2 Pfizer, Inc. Business Overview
  7.3.3 Pfizer, Inc. Eisenmenger Syndrome Treatment Major Product Offerings
  7.3.4 Pfizer, Inc. Eisenmenger Syndrome Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pfizer, Inc. Key News
7.4 Teva Pharmaceutical Industries Ltd.
  7.4.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
  7.4.2 Teva Pharmaceutical Industries Ltd. Business Overview
  7.4.3 Teva Pharmaceutical Industries Ltd. Eisenmenger Syndrome Treatment Major Product Offerings
  7.4.4 Teva Pharmaceutical Industries Ltd. Eisenmenger Syndrome Treatment Revenue in Global Market (2017-2022)
  7.4.5 Teva Pharmaceutical Industries Ltd. Key News
7.5 AstraZeneca plc.
  7.5.1 AstraZeneca plc. Corporate Summary
  7.5.2 AstraZeneca plc. Business Overview
  7.5.3 AstraZeneca plc. Eisenmenger Syndrome Treatment Major Product Offerings
  7.5.4 AstraZeneca plc. Eisenmenger Syndrome Treatment Revenue in Global Market (2017-2022)
  7.5.5 AstraZeneca plc. Key News
7.6 Novartis AG
  7.6.1 Novartis AG Corporate Summary
  7.6.2 Novartis AG Business Overview
  7.6.3 Novartis AG Eisenmenger Syndrome Treatment Major Product Offerings
  7.6.4 Novartis AG Eisenmenger Syndrome Treatment Revenue in Global Market (2017-2022)
  7.6.5 Novartis AG Key News
7.7 Merck & Co., Inc.
  7.7.1 Merck & Co., Inc. Corporate Summary
  7.7.2 Merck & Co., Inc. Business Overview
  7.7.3 Merck & Co., Inc. Eisenmenger Syndrome Treatment Major Product Offerings
  7.7.4 Merck & Co., Inc. Eisenmenger Syndrome Treatment Revenue in Global Market (2017-2022)
  7.7.5 Merck & Co., Inc. Key News
7.8 GlaxoSmithKline plc.
  7.8.1 GlaxoSmithKline plc. Corporate Summary
  7.8.2 GlaxoSmithKline plc. Business Overview
  7.8.3 GlaxoSmithKline plc. Eisenmenger Syndrome Treatment Major Product Offerings
  7.8.4 GlaxoSmithKline plc. Eisenmenger Syndrome Treatment Revenue in Global Market (2017-2022)
  7.8.5 GlaxoSmithKline plc. Key News
7.9 Mylan N.V.
  7.9.1 Mylan N.V. Corporate Summary
  7.9.2 Mylan N.V. Business Overview
  7.9.3 Mylan N.V. Eisenmenger Syndrome Treatment Major Product Offerings
  7.9.4 Mylan N.V. Eisenmenger Syndrome Treatment Revenue in Global Market (2017-2022)
  7.9.5 Mylan N.V. Key News
7.10 Bayer AG
  7.10.1 Bayer AG Corporate Summary
  7.10.2 Bayer AG Business Overview
  7.10.3 Bayer AG Eisenmenger Syndrome Treatment Major Product Offerings
  7.10.4 Bayer AG Eisenmenger Syndrome Treatment Revenue in Global Market (2017-2022)
  7.10.5 Bayer AG Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Eisenmenger Syndrome Treatment Market Opportunities & Trends in Global Market
Table 2. Eisenmenger Syndrome Treatment Market Drivers in Global Market
Table 3. Eisenmenger Syndrome Treatment Market Restraints in Global Market
Table 4. Key Players of Eisenmenger Syndrome Treatment in Global Market
Table 5. Top Eisenmenger Syndrome Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Eisenmenger Syndrome Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Eisenmenger Syndrome Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Eisenmenger Syndrome Treatment Product Type
Table 9. List of Global Tier 1 Eisenmenger Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Eisenmenger Syndrome Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Eisenmenger Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Eisenmenger Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Eisenmenger Syndrome Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Eisenmenger Syndrome Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Eisenmenger Syndrome Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Eisenmenger Syndrome Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Actelion Pharmaceuticals Ltd. Corporate Summary
Table 31. Actelion Pharmaceuticals Ltd. Eisenmenger Syndrome Treatment Product Offerings
Table 32. Actelion Pharmaceuticals Ltd. Eisenmenger Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Gilead Sciences, Inc. Corporate Summary
Table 34. Gilead Sciences, Inc. Eisenmenger Syndrome Treatment Product Offerings
Table 35. Gilead Sciences, Inc. Eisenmenger Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer, Inc. Corporate Summary
Table 37. Pfizer, Inc. Eisenmenger Syndrome Treatment Product Offerings
Table 38. Pfizer, Inc. Eisenmenger Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 40. Teva Pharmaceutical Industries Ltd. Eisenmenger Syndrome Treatment Product Offerings
Table 41. Teva Pharmaceutical Industries Ltd. Eisenmenger Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 42. AstraZeneca plc. Corporate Summary
Table 43. AstraZeneca plc. Eisenmenger Syndrome Treatment Product Offerings
Table 44. AstraZeneca plc. Eisenmenger Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Novartis AG Corporate Summary
Table 46. Novartis AG Eisenmenger Syndrome Treatment Product Offerings
Table 47. Novartis AG Eisenmenger Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Merck & Co., Inc. Corporate Summary
Table 49. Merck & Co., Inc. Eisenmenger Syndrome Treatment Product Offerings
Table 50. Merck & Co., Inc. Eisenmenger Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 51. GlaxoSmithKline plc. Corporate Summary
Table 52. GlaxoSmithKline plc. Eisenmenger Syndrome Treatment Product Offerings
Table 53. GlaxoSmithKline plc. Eisenmenger Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Mylan N.V. Corporate Summary
Table 55. Mylan N.V. Eisenmenger Syndrome Treatment Product Offerings
Table 56. Mylan N.V. Eisenmenger Syndrome Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Bayer AG Corporate Summary
Table 58. Bayer AG Eisenmenger Syndrome Treatment Product Offerings
Table 59. Bayer AG Eisenmenger Syndrome Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Eisenmenger Syndrome Treatment Segment by Type in 2021
Figure 2. Eisenmenger Syndrome Treatment Segment by Application in 2021
Figure 3. Global Eisenmenger Syndrome Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Eisenmenger Syndrome Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Eisenmenger Syndrome Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Eisenmenger Syndrome Treatment Revenue in 2021
Figure 8. By Type - Global Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028
Figure 12. US Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028
Figure 24. China Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Eisenmenger Syndrome Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Eisenmenger Syndrome Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Actelion Pharmaceuticals Ltd. Eisenmenger Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Gilead Sciences, Inc. Eisenmenger Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer, Inc. Eisenmenger Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Teva Pharmaceutical Industries Ltd. Eisenmenger Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. AstraZeneca plc. Eisenmenger Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis AG Eisenmenger Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Merck & Co., Inc. Eisenmenger Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. GlaxoSmithKline plc. Eisenmenger Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mylan N.V. Eisenmenger Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Bayer AG Eisenmenger Syndrome Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)